Clinical Trials Directory

Trials / Completed

CompletedNCT04018456

Regenerative Endodontic Treatment of Mature Necrotic Teeth With Apical Periodontitis

Regenerative Root Canal Treatment of Mature Teeth With Pulp Necrosis and Apical Periodontitis Using Biodentine Compared With MTA: Randomized Clinical Double-blind Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
10 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective, randomized, controlled double-blind study is to evaluate the effectiveness of biodentine compared with MTA used as pulp space barrier on discoloration of teeth after regenerative based non-obturation root canal treatment in mature single canal with pulp necrosis and apical periodontitis.

Detailed description

• Regenerative endodontic treatment will be performed through two visits: First visit aims to clean and disinfect the tooth canal by copious irrigation with NaOCL and EDTA solution . At the end of first visit, canal will be dressed by CaOH as intracanal medicaments. Second visit will be after two weeks. After removal of CaOH dressing by copius irrigation, evoking bleeding inside canal by over instrumentation. When blood become semi-coagulated, according to the random sequence number of the participants, either biodentine or white MTA will be placed as pulp space barrier. At the end of treatment, the access cavity will be sealed with composite restoration.

Conditions

Interventions

TypeNameDescription
OTHERBiodentineBiodentine is calcium silicate based cement which is bioactive and inductive material. Biodentine will be applied as coronal plug material.
OTHERWhite MTAMTA is calcium silicate based cement which is bioactive and inductive material. MTA is used in most cases of regenerative endodontics and it will be applied as coronal plug material.

Timeline

Start date
2021-08-01
Primary completion
2022-01-01
Completion
2023-06-01
First posted
2019-07-12
Last updated
2024-01-23

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04018456. Inclusion in this directory is not an endorsement.